Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Monkeypox: how will we know if the treatments work?
Rojek A, Dunning J, Olliaro P. Rojek A, et al. Among authors: olliaro p. Lancet Infect Dis. 2022 Sep;22(9):1269-1270. doi: 10.1016/S1473-3099(22)00514-X. Epub 2022 Aug 2. Lancet Infect Dis. 2022. PMID: 35931096 Free PMC article. No abstract available.
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial.
Dunning J, Sahr F, Rojek A, Gannon F, Carson G, Idriss B, Massaquoi T, Gandi R, Joseph S, Osman HK, Brooks TJ, Simpson AJ, Goodfellow I, Thorne L, Arias A, Merson L, Castle L, Howell-Jones R, Pardinaz-Solis R, Hope-Gill B, Ferri M, Grove J, Kowalski M, Stepniewska K, Lang T, Whitehead J, Olliaro P, Samai M, Horby PW; RAPIDE-TKM trial team. Dunning J, et al. Among authors: olliaro p. PLoS Med. 2016 Apr 19;13(4):e1001997. doi: 10.1371/journal.pmed.1001997. eCollection 2016 Apr. PLoS Med. 2016. PMID: 27093560 Free PMC article. Clinical Trial.
Experimental Treatment of Ebola Virus Disease with Brincidofovir.
Dunning J, Kennedy SB, Antierens A, Whitehead J, Ciglenecki I, Carson G, Kanapathipillai R, Castle L, Howell-Jones R, Pardinaz-Solis R, Grove J, Scott J, Lang T, Olliaro P, Horby PW; RAPIDE-BCV trial team. Dunning J, et al. Among authors: olliaro p. PLoS One. 2016 Sep 9;11(9):e0162199. doi: 10.1371/journal.pone.0162199. eCollection 2016. PLoS One. 2016. PMID: 27611077 Free PMC article. Clinical Trial.
Global outbreak research: harmony not hegemony.
ISARIC clinical characterisation group. ISARIC clinical characterisation group. Lancet Infect Dis. 2020 Jul;20(7):770-772. doi: 10.1016/S1473-3099(20)30440-0. Epub 2020 Jun 2. Lancet Infect Dis. 2020. PMID: 32502433 Free PMC article. No abstract available.
What does 95% COVID-19 vaccine efficacy really mean?
Olliaro P. Olliaro P. Lancet Infect Dis. 2021 Jun;21(6):769. doi: 10.1016/S1473-3099(21)00075-X. Epub 2021 Feb 17. Lancet Infect Dis. 2021. PMID: 33609458 Free PMC article. No abstract available.
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
Drake TM, Riad AM, Fairfield CJ, Egan C, Knight SR, Pius R, Hardwick HE, Norman L, Shaw CA, McLean KA, Thompson AAR, Ho A, Swann OV, Sullivan M, Soares F, Holden KA, Merson L, Plotkin D, Sigfrid L, de Silva TI, Girvan M, Jackson C, Russell CD, Dunning J, Solomon T, Carson G, Olliaro P, Nguyen-Van-Tam JS, Turtle L, Docherty AB, Openshaw PJ, Baillie JK, Harrison EM, Semple MG; ISARIC4C investigators. Drake TM, et al. Among authors: olliaro p. Lancet. 2021 Jul 17;398(10296):223-237. doi: 10.1016/S0140-6736(21)00799-6. Lancet. 2021. PMID: 34274064 Free PMC article.
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort.
ISARIC Clinical Characterisation Group; Hall MD, Baruch J, Carson G, Citarella BW, Dagens A, Dankwa EA, Donnelly CA, Dunning J, Escher M, Kartsonaki C, Merson L, Pritchard M, Wei J, Horby PW, Rojek A, Olliaro PL. ISARIC Clinical Characterisation Group, et al. Elife. 2021 Nov 23;10:e70970. doi: 10.7554/eLife.70970. Elife. 2021. PMID: 34812731 Free PMC article.
472 results